Introduction: Studies investigating the risk of gallstones in the Japanese population are sparse. To our knowledge, this is the first prospective cohort study assessing risk factors of gallstones in Japan. Methods: A nationwide population-based prospective cohort of 112,109 men and women, aged 40–69 years, self-completed questionnaires at baseline regarding exposures to potential risk factors, between 1990 and 1994. The occurrence of gallstones and cholecystectomy for gallstones were ascertained from another questionnaire after 10 years. Odds ratios and the 95% confidence intervals were calculated using the multivariate logistic regression. Results: During the 10-year follow-up, 3,092 (5.0%) participants developed gallstones and 729 (1.2%) participants required cholecystectomy. Increasing age, high body mass index, and diabetes mellitus were associated with the risk of gallstones in both sexes. In men, weight gain or loss of >5 kg over the follow-up period and stress were associated with risk of gallstones, whereas alcohol intake was inversely associated with the risk. In women, weight gain of >5 kg during the follow-up period, smoking, menopause, and lipid-lowering drugs were associated with risk of gallstones, whereas late onset of menarche was inversely associated with risk of gallstones. The risk of cholecystectomy broadly reflected the risk of gallstones for both sexes respectively. Conclusion: Risk factors for both gallstones and cholecystectomy for gallstones are multifactorial and differ between men and women. Novel findings in this study include an inverse association between late onset of menarche and gallstones, and an association between self-reported stress in men and gallstones.

1.
Nomura
H
,
Kashiwagi
S
,
Hayashi
J
,
Kajiyama
W
,
Ikematsu
H
,
Noguchi
A
,
Prevalence of gallstone disease in a general population of Okinawa, Japan
.
Am J Epidemiol
.
1988
;
128
:
598
605
. .
2.
Aerts
R
,
Penninckx
F
.
The burden of gallstone disease in Europe
.
Aliment Pharmacol Ther
.
2003
;
18
(
Suppl 3
):
49
53
. .
3.
Everhart
JE
,
Khare
M
,
Hill
M
,
Maurer
KR
.
Prevalence and ethnic differences in gallbladder disease in the United States
.
Gastroenterology
.
1999
;
117
:
632
9
. .
4.
Everhart
JE
,
Ruhl
CE
.
Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases
.
Gastroenterology
.
2009
;
136
:
376
86
. .
5.
Brazzelli
M
,
Cruickshank
M
,
Kilonzo
M
,
Ahmed
I
,
Stewart
F
,
McNamee
P
,
Systematic review of the clinical and cost effectiveness of cholecystectomy versus observation/conservative management for uncomplicated symptomatic gallstones or cholecystitis
.
Surg Endosc
.
2015
;
29
:
637
47
.
6.
Gurusamy
KS
,
Davidson
BR
.
Gallstones
.
BMJ
.
2014
;
348
:
g2669
. .
7.
Gracie
WA
,
Ransohoff
DF
.
The natural history of silent gallstones: the innocent gallstone is not a myth
.
N Engl J Med
.
1982
;
307
:
798
800
. .
8.
Friedman
GD
,
Raviola
CA
,
Fireman
B
.
Prognosis of gallstones with mild or no symptoms: 25 years of follow-up in a health maintenance organization
.
J Clin Epidemiol
.
1989
;
42
:
127
36
. .
9.
McSherry
CK
,
Ferstenberg
H
,
Calhoun
WF
,
Lahman
E
,
Virshup
M
.
The natural history of diagnosed gallstone disease in symptomatic and asymptomatic patients
.
Ann Surg
.
1985
;
202
:
59
63
. .
10.
Wada
K
,
Wada
K
,
Imamura
T
.
[Natural course of asymptomatic gallstone disease]
.
Nippon Rinsho
.
1993
;
51
:
1737
43
.
11.
Halldestam
I
,
Enell
EL
,
Kullman
E
,
Borch
K
.
Development of symptoms and complications in individuals with asymptomatic gallstones
.
Br J Surg
.
2004
;
91
:
734
8
. .
12.
Cucchiaro
G
,
Rossitch
JC
,
Bowie
J
,
Branum
GD
,
Niotis
MT
,
Watters
CR
,
Clinical significance of ultrasonographically detected coincidental gallstones
.
Dig Dis Sci
.
1990
;
35
:
417
21
. .
13.
Kelly
TR
.
Gallsonte pancreatitis
.
Arch Surg
.
1974
;
109
:
294
7
. .
14.
Ishiguro
S
,
Inoue
M
,
Kurahashi
N
,
Iwasaki
M
,
Sasazuki
S
,
Tsugane
S
.
Risk factors of biliary tract cancer in a large-scale population-based cohort study in Japan (JPHC study); with special focus on cholelithiasis, body mass index, and their effect modification
.
Cancer Causes Control
.
2008
;
19
:
33
41
. .
15.
Yajima
H
,
Kanai
H
,
Son
K
,
Yoshida
K
,
Yanaga
K
.
Reasons and risk factors for intraoperative conversion from laparoscopic to open cholecystectomy
.
Surg Today
.
2014
;
44
:
80
3
. .
16.
Asai
K
,
Watanabe
M
,
Kusachi
S
,
Matsukiyo
H
,
Saito
T
,
Kodama
H
,
Risk factors for conversion of laparoscopic cholecystectomy to open surgery associated with the severity characteristics according to the Tokyo guidelines
.
Surg Today
.
2014
;
44
:
2300
4
. .
17.
Zacks
SL
,
Sandler
RS
,
Rutledge
R
,
Brown
RS
.
A population-based cohort study comparing laparoscopic cholecystectomy and open cholecystectomy
.
Am J Gastroenterol
.
2002
;
97
:
334
40
. .
18.
Katsika
D
,
Grjibovski
A
,
Einarsson
C
,
Lammert
F
,
Lichtenstein
P
,
Marschall
HU
.
Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs
.
Hepatology
.
2005
;
41
:
1138
43
. .
19.
Bennion
LJ
,
Grundy
SM
.
Risk factors for the development of cholelithiasis in man (second of two parts)
.
N Engl J Med
.
1978
;
299
:
1221
7
. .
20.
Scragg
RK
,
McMichael
AJ
,
Seamark
RF
.
Oral contraceptives, pregnancy, and endogenous oestrogen in gall stone disease--a case-control study
.
Br Med J (Clin Res Ed)
.
1984
;
288
:
1795
9
. .
21.
Scragg
RK
,
McMichael
AJ
,
Baghurst
PA
.
Diet, alcohol, and relative weight in gall stone disease: a case-control study
.
Br Med J (Clin Res Ed)
.
1984
;
288
:
1113
9
. .
22.
Dowling
RH
,
Veysey
MJ
,
Pereira
SP
,
Hussaini
SH
,
Thomas
LA
,
Wass
JA
,
Role of intestinal transit in the pathogenesis of gallbladder stones
.
Can J Gastroenterol
.
1997
;
11
:
57
64
. .
23.
Chapman
BA
,
Wilson
IR
,
Frampton
CM
,
Chisholm
RJ
,
Stewart
NR
,
Eagar
GM
,
Prevalence of gallbladder disease in diabetes mellitus
.
Dig Dis Sci
.
1996
;
41
:
2222
8
.
24.
Lambou-Gianoukos
S
,
Heller
SJ
.
Lithogenesis and bile metabolism
.
Surg Clin North Am
.
2008
;
88
:
1175
94
. .
25.
Marschall
HU
,
Einarsson
C
.
Gallstone disease
.
J Intern Med
.
2007
;
261
:
529
42
. .
26.
Kameda
H
,
Ishihara
F
,
Shibata
K
,
Tsukie
E
.
Clinical and nutritional study on gallstone disease in Japan
.
Jpn J Med
.
1984
;
23
:
109
13
. .
27.
Nagase
M
,
Tanimura
H
,
Setoyama
M
,
Hikasa
Y
.
Present features of gallstones in Japan. A collective review of 2,144 cases
.
Am J Surg
.
1978
;
135
:
788
90
. .
28.
Nakayama
F
,
Miyake
H
.
Changing state of gallstone disease in Japan. Composition of the stones and treatment of the condition
.
Am J Surg
.
1970
;
120
:
794
9
. .
29.
Tsugane
S
,
Sasaki
S
,
Tsubono
Y
.
Under- and overweight impact on mortality among middle-aged Japanese men and women: a 10-y follow-up of JPHC study cohort I
.
Int J Obes Relat Metab Disord
.
2002
;
26
:
529
37
. .
30.
Otani
T
,
Iwasaki
M
,
Yamamoto
S
,
Sobue
T
,
Hanaoka
T
,
Inoue
M
,
Japan Public Health Center-based Prospective Study GroupAlcohol consumption, smoking, and subsequent risk of colorectal cancer in middle-aged and elderly Japanese men and women: Japan Public Health Center-based prospective study
.
Cancer Epidemiol Biomarkers Prev
.
2003
;
12
:
1492
500
.
31.
Cirillo
DJ
,
Wallace
RB
,
Rodabough
RJ
,
Greenland
P
,
LaCroix
AZ
,
Limacher
MC
,
Effect of estrogen therapy on gallbladder disease
.
JAMA
.
2005
;
293
:
330
9
. .
32.
Uhler
ML
,
Marks
JW
,
Voigt
BJ
,
Judd
HL
.
Comparison of the impact of transdermal versus oral estrogens on biliary markers of gallstone formation in postmenopausal women
.
J Clin Endocrinol Metab
.
1998
;
83
:
410
4
. .
33.
Earley
RL
,
Blumer
LS
,
Grober
MS
.
The gall of subordination: changes in gall bladder function associated with social stress
.
Proc Biol Sci
.
2004
;
271
:
7
13
. .
34.
Jensen
KH
,
Jørgensen
T
.
Incidence of gallstones in a Danish population
.
Gastroenterology
.
1991
;
100
:
790
4
. .
35.
Banim
PJ
,
Luben
RN
,
Bulluck
H
,
Sharp
SJ
,
Wareham
NJ
,
Khaw
KT
,
The aetiology of symptomatic gallstones quantification of the effects of obesity, alcohol and serum lipids on risk. Epidemiological and biomarker data from a UK prospective cohort study (EPIC-Norfolk)
.
Eur J Gastroenterol Hepatol
.
2011
;
23
:
733
40
. .
36.
Grodstein
F
,
Colditz
GA
,
Hunter
DJ
,
Manson
JE
,
Willett
WC
,
Stampfer
MJ
.
A prospective study of symptomatic gallstones in women: relation with oral contraceptives and other risk factors
.
Obstet Gynecol
.
1994
;
84
:
207
14
.
37.
Yang
H
,
Petersen
GM
,
Roth
MP
,
Schoenfield
LJ
,
Marks
JW
.
Risk factors for gallstone formation during rapid loss of weight
.
Dig Dis Sci
.
1992
;
37
:
912
8
. .
38.
Bennion
LJ
,
Grundy
SM
.
Effects of obesity and caloric intake on biliary lipid metabolism in man
.
J Clin Invest
.
1975
;
56
:
996
1011
. .
39.
Freeman
JB
,
Meyer
PD
,
Printen
KJ
,
Mason
EE
,
DenBesten
L
.
Analysis of gallbladder bile in morbid obesity
.
Am J Surg
.
1975
;
129
:
163
6
. .
40.
Marzio
L
,
Capone
F
,
Neri
M
,
Mezzetti
A
,
De Angelis
C
,
Cuccurullo
F
.
Gallbladder kinetics in obese patients. Effect of a regular meal and low-calorie meal
.
Dig Dis Sci
.
1988
;
33
:
4
9
. .
41.
Weinsier
RL
,
Ullmann
DO
.
Gallstone formation and weight loss
.
Obes Res
.
1993
;
1
:
51
6
. .
42.
De Santis
A
,
Attili
AF
,
Ginanni Corradini
S
,
Scafato
E
,
Cantagalli
A
,
De Luca
C
,
Gallstones and diabetes: a case-control study in a free-living population sample
.
Hepatology
.
1997
;
25
:
787
90
. .
43.
Maurer
KR
,
Everhart
JE
,
Knowler
WC
,
Shawker
TH
,
Roth
HP
.
Risk factors for gallstone disease in the Hispanic populations of the United States
.
Am J Epidemiol
.
1990
;
131
:
836
44
. .
44.
Ruhl
CE
,
Everhart
JE
.
Association of diabetes, serum insulin, and c-peptide with gallbladder disease
.
Hepatology
.
2000
;
31
:
299
303
. .
45.
Sampliner
RE
,
Bennett
PH
,
Comess
LJ
,
Rose
FA
,
Burch
TA
.
Gallbladder disease in pima indians. Demonstration of high prevalence and early onset by cholecystography
.
N Engl J Med
.
1970
;
283
:
1358
64
. .
46.
Barbara
L
,
Sama
C
,
Morselli Labate
AM
,
Taroni
F
,
Rusticali
AG
,
Festi
D
,
A population study on the prevalence of gallstone disease: the Sirmione Study
.
Hepatology
.
1987
;
7
:
913
7
. .
47.
Jørgensen
T
.
Gall stones in a Danish population. Relation to weight, physical activity, smoking, coffee consumption, and diabetes mellitus
.
Gut
.
1989
;
30
:
528
34
. .
48.
Thornton
J
,
Symes
C
,
Heaton
K
.
Moderate alcohol intake reduces bile cholesterol saturation and raises HDL cholesterol
.
Lancet
.
1983
;
2
:
819
22
. .
49.
Saluja
AK
,
Bhagat
L
.
Pathophysiology of alcohol-induced pancreatic injury
.
Pancreas
.
2003
;
27
:
327
31
. .
50.
De Pancorbo
CM
,
Carballo
F
,
Horcajo
P
,
Aldeguer
M
,
De La Villa
I
,
Nieto
E
,
Prevalence and associated factors for gallstone disease: results of a population survey in Spain
.
J Clin Epidemiol
.
1997
;
50
:
1347
55
.
51.
Hopper
KD
,
Landis
JR
,
Meilstrup
JW
,
McCauslin
MA
,
Sechtin
AG
.
The prevalence of asymptomatic gallstones in the general population
.
Invest Radiol
.
1991
;
26
:
939
45
. .
52.
The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO)
.
The epidemiology of gallstone disease in Rome, Italy. Part II. Factors associated with the disease
.
Hepatology
.
1988
;
8
:
907
13
.
53.
Diehl
AK
,
Haffner
SM
,
Hazuda
HP
,
Stern
MP
.
Coronary risk factors and clinical gallbladder disease: an approach to the prevention of gallstones?
Am J Public Health
.
1987
;
77
:
841
5
. .
54.
Pastides
H
,
Tzonou
A
,
Trichopoulos
D
,
Katsouyanni
K
,
Trichopoulou
A
,
Kefalogiannis
N
,
A case-control study of the relationship between smoking, diet, and gallbladder disease
.
Arch Intern Med
.
1990
;
150
:
1409
12
. .
55.
Tsai
CJ
,
Leitzmann
MF
,
Willett
WC
,
Giovannucci
EL
.
Statin use and the risk of cholecystectomy in women
.
Gastroenterology
.
2009
;
136
:
1593
600
. .
56.
Heady
JA
.
A cooperative trial in the primary prevention of ischaemic heart disease using clofibrate: some statistical aspects
.
Control Clin Trials
.
1981
;
1
:
383
92
.
57.
Shaffer
EA
.
Gallstone disease: epidemiology of gallbladder stone disease
.
Best Pract Res Clin Gastroenterol
.
2006
;
20
:
981
96
. .
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.